Cipralex, Cymbalta and Agomelatine Showed Better Results Than Prozac in Long-Term Depression Treatment

In depth

A meta-analysis published in The Lancet Psychiatry examined data from 115 randomized trials. The study included 30,428 adults with major depression, and 21 antidepressant drugs were evaluated.

According to the findings, Cipralex, Cymbalta and Agomelatine showed better results than Prozac in long-term treatment. The study examined whether the improvement was maintained over time and whether treatment could be continued without side effects or other difficulties causing it to be stopped.

The researchers said there is no reason to switch a medication that is already helping the patient. Against the backdrop of the surge in antidepressant purchases in Israel, the study presents a comparison of the drugs in maintaining improvement over time.